Publications by authors named "Suwanna Vangveravong"
Page 1 of 1
Synopsis of recent research by authors named "Suwanna Vangveravong"
- Suwanna Vangveravong's recent research centers on the development of sigma-2 ligands as targeted therapeutics for cancer treatment, specifically focusing on their ability to enhance drug delivery and induce apoptosis in various cancer models, including ovarian and pancreatic cancers.
- Noteworthy findings include the discovery that combining sigma-2 ligands with SMAC mimetics improves effectiveness against cancer cells and reduces susceptibility to drug resistance mechanisms, highlighting their potential as effective cancer therapies.
- Vangveravong's work also explores innovative drug delivery methods, such as using gold nanocages and conjugated compounds, which aim to specifically target cancer stem cells and improve therapeutic outcomes while minimizing off-target effects.
